Fever News and Research

RSS

Natural bioactive molecules can relieve cold and flu symptoms

Researchers at Applied Biological Laboratories Inc. discovered how natural bioactive molecules can effectively relieve cold and flu symptoms by protecting the mucosal barrier function and reducing inflammation during these infections.

16 Aug 2023

Scientists develop novel animal model of neurobrucellosis

Neurobrucellosis is a severe long-term complication of brucellosis, one of the most common bacterial zoonotic diseases.

10 Aug 2023

Adenovirus infection linked to rare blood clotting disorder

Platelets, or thrombocytes, are specialized cellular fragments that form blood clots when we get scrapes and traumatic injuries. Viral infections, autoimmune disease, and other conditions can cause platelet levels to drop throughout the body, termed thrombocytopenia.

10 Aug 2023

Is a Western diet a risk factor for major depressive disorder?

Researchers investigated whether the Western diet (WD) was a risk element for major depressive disorder (MDD) patients.

8 Aug 2023

Study reveals link between self-perceived antibody response and actual COVID-19 protection

Can individuals assess the strength of their antibody response following coronavirus disease 2019?

8 Aug 2023

UKHSA unveils world-leading Vaccine Development and Evaluation Centre

The UK Health Security Agency (UKHSA) has today unveiled its world-leading Vaccine Development and Evaluation Centre (VDEC), which is building on its pandemic legacy and helping develop life-saving new vaccines for the UK and worldwide.

7 Aug 2023

Omicron variant resembles other respiratory viruses, posing challenges for syndromic surveillance

Researchers describe the symptom profiles of respiratory viral infections.

4 Aug 2023

Study reports the first protein-based diagnostic signature to discriminate MIS-C from Kawasaki Disease and other common infections

Researchers explore the distinguishing features of MIS-C as compared to other inflammatory-infectious syndromes in children.

4 Aug 2023

NIH awards $18 million to develop novel chikungunya vaccine

The Access to Advanced Health Institute (AAHI) announced today that it has received an $18 million award from the National Institutes of Health (NIH) to develop a temperature stable, single-dose vaccine candidate for the chikungunya virus.

3 Aug 2023

Novel molecules inspired by the immune system inactivate several viruses

Antiviral therapies are notoriously difficult to develop, as viruses can quickly mutate to become resistant to drugs. But what if a new generation of antivirals ignores the fast-mutating proteins on the surface of viruses and instead disrupts their protective layers?

2 Aug 2023

Peptoid antiviral therapy inactivates three viruses in lab tests

Just as bacteria can develop antibiotic resistance, viruses can also evade drug treatments. Developing therapies against these microbes is difficult because viruses often mutate or hide themselves within cells.

2 Aug 2023

CHLA expert offers update on the latest COVID-19 vaccine information and precautions

The coronavirus pandemic is no longer a national emergency, but the virus that causes COVID-19 isn't gone-;and neither is the risk of getting the disease.

2 Aug 2023

Added sugar consumption linked to greater risk of kidney stones

Between 7% and 15% of people in North America, between 5% and 9% of people in Europe, and between 1% and 5% of people in Asia suffer from kidney stones.

2 Aug 2023

Expert warns of the increasing risks of European holidays

As the UKHSA issues new essential health guidance for travellers going abroad, a leading testing expert warns of the increasing risks of European holidays.

28 Jul 2023

Arthritis affects 220,000 children and teens, according to a new CDC study

In a recent MMWR published by the United States CDC, researchers combine survey data from the NSCH collected over a five-year period to estimate the prevalence of arthritis.

26 Jul 2023

Describing patterns of pediatric allergies across the United States using EHR

In the largest study of its kind, researchers from Children's Hospital of Philadelphia (CHOP) used electronic health record (EHR) data from more than 200,000 pediatric patients to describe patterns of pediatric allergies across the United States, validating a population-level pattern of allergy development known as the "allergic march," in which allergies first present as eczema, followed by food allergies, asthma, and environmental allergies.

25 Jul 2023

Probiotic combination could reduce incidence of toxic shock syndrome

The widespread, pathogenic microbe Staphylococcus aureus can colonize the skin and mucous membranes throughout the body, particularly the vagina and gastrointestinal tract.

21 Jul 2023

Flu and COVID-19 report offers latest surveillance data and public health advice

This fortnightly flu and COVID-19 report brings together the latest surveillance data along with the latest public health advice.

21 Jul 2023

CEPI and HMRI partner to accelerate development of pandemic vaccines

CEPI, the Coalition for Epidemic Preparedness Innovations, and the Houston Methodist Research Institute (HMRI), have today announced a partnership to combine cutting-edge artificial intelligence (AI) technology with established laboratory techniques to speed up development of future vaccines against novel viral threats (also known as Disease X).

18 Jul 2023